Open AccessAssociation of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease
Author(s) -
Adam M. Staffaroni,
Abigail O. Kramer,
Megan Casey,
Huicong Kang,
Julio C. Rojas,
Christina D. Orrú,
Byron Caughey,
Isabel E. Allen,
Joel H. Kramer,
Howard J. Rosen,
Kaj Blennow,
Henrik Zetterberg,
Michael D. Geschwind
Publication year - 2019
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2019.1071
Subject(s) - medicine , cerebrospinal fluid , hazard ratio , biomarker , oncology , cohort , tau protein , proportional hazards model , enolase , cohort study , alzheimer's disease , disease , pathology , confidence interval , biology , immunohistochemistry , biochemistry
Fluid biomarkers that can predict survival time in sporadic Creutzfeldt-Jakob disease (sCJD) will be critical for clinical care and for treatment trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom